Matthew Scalo

Matthew Scalo

Investor Relations Kontakt på MYRIAD GENETICS, INC.
Finance
Health Technology
Consumer Services

Profil

Matthew Scalo is Senior Vice President-Investor Relations at Myriad Genetics, Inc. since 2022.
Former roles include Senior Director-Investor Relations at Luminex Corp., Investor Relations Contact at NextGen Healthcare, Inc., Senior Research Analyst at Allspring Global Investments LLC, Research Analyst at Canaccord Adams, Inc. from 2004 to 2010, VP, Investor Relations & Corporate Development at Cutera, Inc., Associate at Broadpoint.
Gleacher Securities in 2003, and Research Analyst at Canaccord Genuity, Inc. in 2010.
Education includes an MBA from the University of Notre Dame and an undergraduate degree from the University of California, Davis.

Aktiva positioner av Matthew Scalo

FöretagPositionStart
MYRIAD GENETICS, INC. Investor Relations Kontakt 2022-08-01

Tidigare kända positioner av Matthew Scalo

FöretagPositionSlut
Analyst-Equity 2010-12-31
Analyst-Equity 2010-04-22
Analyst-Equity 2003-12-31
Analyst-Equity 2002-12-31
NEXTGEN HEALTHCARE, INC. Investor Relations Kontakt -
Se detaljerna i Matthew Scalos erfarenhet

Matthew Scalos utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

76

Första gradens relationer

10

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag10

Technology Services

Health Technology

Finance

Health Technology

Finance

Health Technology

Consumer Services

Finance

Consumer Services

Finance

  1. Börsen
  2. Insiders
  3. Matthew Scalo